The 7 Questions to Ask a Behavioral Health AI Vendor Before You Sign

Not all AI is created equal, and in behavioral health the difference is measured in patient safety. When a model’s output can shape how a person in crisis is screened, monitored, or treated, choosing an AI partner is not a software decision. It is a clinical one.

That makes the evaluation less about the pitch and more about what you can verify before you sign. The seven questions below are a buyer’s litmus test. Ask them of any behavioral health AI vendor, and the answers will tell you whether a tool is built to hold up in real clinical use, or just to win the deal.

What is the clinical validation, and against what standard?

Start with the simplest question: does it work, and how do you know? The best healthcare AI is tested outside the lab, with real patients and clinicians in diverse settings, not only against benchmark datasets. Ask which populations the model was validated on across age, race, and gender, and what accuracy metrics it produced when measured against a recognized clinical standard. Ask to see validation studies, pilot results, or published research. Clinical relevance beats theoretical promise, and a vendor who cannot point to either is asking you to take performance on faith.

Will they show you the model card?

A model card is a nutrition label for AI. It explains what data trained the model, how it performs, and where it should and should not be used. A strong vendor shares one without being pushed, because transparency is part of how they earn clinical trust. Hesitation is a red flag. No model card means a black box, and in a clinical setting a black box is a risk you inherit. This is the same case Videra has made before about why model cards matter when selecting an AI vendor: if you cannot see how a model was built, you cannot defend how it is used.

How do they find and fix bias, and can they explain an output?

Bias in healthcare AI is not hypothetical. A widely cited analysis published in Science found that a commonly used health-risk algorithm systematically under-identified Black patients for additional care, and that correcting the flaw would have raised the share of Black patients flagged for extra help from 17.7% to 46.5%. The model was not malicious. It used cost as a proxy for need, and unequal spending did the rest. That is exactly how bias enters a clinical tool: quietly, through a design choice no one flagged.

So ask how a vendor tests for bias across populations, how often they check, and what they do when they find it. Ask whether they can explain why the model produced a given output. “We are not sure why it flagged that” is not an answer you want to hear about a patient.

Where does your data live, and how is it protected?

Behavioral health data is among the most sensitive a person ever generates. HIPAA compliance is the floor, not the ceiling. Ask where data is stored, who can access it, and how it is encrypted in transit and at rest. Ask whether your patients’ data will be used to train models that serve other customers. Ask whether the vendor will submit to a third-party security audit and share the result. A vendor who treats these as routine questions has done the work. One who treats them as friction has not.

What happens after go-live: drift, monitoring, and retraining?

AI is not “set it and forget it.” Models drift as patients, documentation patterns, and clinical practice change, and performance can degrade without anyone noticing. Ask how often the model is monitored and updated, whether its performance has actually been measured over time, and whether the workflow includes clinicians reviewing AI outputs. In healthcare, human oversight is not a nicety, it is the safeguard. The answer you want describes a continuous process, not a launch date.

What does it actually ask of the clinician?

This is the question most buyers skip, and it predicts more than any other. A capable model that lives outside the daily workflow gets abandoned once the novelty fades, no matter how good it is. Ask what adoption really requires: a new login, a separate application to manage, a data migration, hours of training during a week no clinician has to spare? Or does the tool meet clinicians inside the systems they already use? The solutions that deliver are the ones that ask close to nothing of an already-stretched team. The first-year adoption data behind tools built into the existing workflow makes the point plainly: low friction is what turns capability into use.

Can they quantify the value, and are they a partner or a vendor?

Finally, ask for proof and for posture. Proof means measurable outcomes: ROI case studies, workflow impact such as documentation time returned, readmissions avoided, or staff hours saved. If a vendor cannot quantify the value, keep looking. Posture means asking whether you are buying software or building a relationship with a team that will monitor results, retrain the model, and evolve as your needs change. Good clinical AI is not a one-time transaction, and the vendors worth choosing do not treat it like one.

What these questions reveal together

None of these questions is about how clever the model is. Every one of them is about whether trust, safety, and adoption were designed in or bolted on afterward. A vendor who answers all seven readily, with evidence, is showing you the work behind the claims. A vendor who flinches at a few of them is telling you something just as useful.

The point of the litmus test is not to find a flawless tool. It is to choose a partner whose answers you could defend to your clinicians, your compliance team, and your board. For a broader view of where behavioral health AI is delivering real value today, and what separates the organizations getting it right, the State of AI in Behavioral Health 2026 report is a useful place to start.